RxDoctor Payments Data

Ryan Lowers, MD

Family Medicine · Vienna, WVNPI 1770791733

Payments from drug & device makers

$185in general payments, 2019–2025

Across 12 payments — averaging $15.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$88
  • Lilly USA, LLC$42
  • Genentech USA, Inc.$18
  • Pacira Therapeutics, Inc.$15
  • AbbVie$11
  • Boehringer Ingelheim$11

What the payments were for

  • Food & beverage$185100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$185 in reported general payments places this provider in the 35th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$119,540
Medicare patients
370
Services billed
1,505

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide145$157,157
OzempicSemaglutide129$135,741
JardianceEmpagliflozin94$104,149
EliquisApixaban86$86,254
JanuviaSitagliptin Phosphate45$45,555
TrulicityDulaglutide37$43,590
Trelegy ElliptaFluticasone/Umeclidin/Vilanter39$25,560
InvokanaCanagliflozin14$22,880
EntrestoSacubitril/Valsartan14$16,997
XareltoRivaroxaban34$14,616
Breo ElliptaFluticasone/Vilanterol33$12,486
Spiriva RespimatTiotropium Bromide22$10,918
Tresiba Flextouch U-100Insulin Degludec22$9,874
Levothyroxine Sodium846$8,424
Pantoprazole Sodium631$6,886

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$42$200,747182 claims
Boehringer IngelheimJardiance, Spiriva Respimat$11$115,067116 claims
AbbVieSynthroid$11$4,83178 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Vienna

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →